SCRIB and breast cancer: Interestingly, the N-terminus of SCRIB is activated in aggressive BC, with the proline-rich C-terminus lost [144], and SCRIB is favorably localized to the cellular protrusions in metastatic cells; blocking SCRIB inhibits the FRP and tumor metastasis [10].